Literature DB >> 10504234

Human cathepsin X: A cysteine protease with unique carboxypeptidase activity.

D K Nägler1, R Zhang, W Tam, T Sulea, E O Purisima, R Ménard.   

Abstract

Cathepsin X is a novel cysteine protease which was identified recently from the EST (expressed sequence tags) database. In a homology model of the mature cathepsin X, a unique three residue insertion between the Gln22 of the oxyanion hole and the active site Cys31 was found to be located in the primed region of the binding cleft as part of a surface loop corresponding to residues His23 to Tyr27, which we have termed the "mini-loop". From the model, it became apparent that this distinctive structural feature might confer exopeptidase activity to the enzyme. To verify this hypothesis, human procathepsin X was expressed in Pichia pastoris and converted to mature cathepsin X using small amounts of human cathepsin L. Cathepsin X was found to display excellent carboxypeptidase activity against the substrate Abz-FRF(4NO(2)), with a k(cat)/K(M) value of 1.23 x 10(5) M(-)(1) s(-)(1) at the optimal pH of 5.0. However, the activity of cathepsin X against the substrates Cbz-FR-MCA and Abz-AFRSAAQ-EDDnp was found to be extremely low, with k(cat)/K(M) values lower than 70 M(-)(1) s(-)(1). Therefore, cathepsin X displays a stricter exopeptidase activity than cathepsin B. No inhibition of cathepsin X by cystatin C could be detected up to a concentration of 4 microM of inhibitor. From a model of the protease complexed with Cbz-FRF, the bound carboxypeptidase substrate is predicted to establish a number of favorable contacts within the cathepsin X binding site, in particular with residues His23 and Tyr27 from the mini-loop. The presence of the mini-loop restricts the accessibility of cystatin C as well as of the endopeptidase and MCA substrates in the primed subsites of the protease. The marked structural and functional differences of cathepsin X relative to other members of the papain family of cysteine proteases will be of great value in designing specific inhibitors useful as research tools to investigate the physiological and potential pathological roles of this novel enzyme.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10504234     DOI: 10.1021/bi991371z

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  27 in total

1.  Cyclic, linear, cycloretro-isomer, and cycloretro-inverso peptides derived from the C-terminal sequence of bradykinin as substrates or inhibitors of serine and cysteine proteases.

Authors:  Aurelio Resende Lima; Luiz Juliano; Maria Aparecida Juliano
Journal:  Protein J       Date:  2004-05       Impact factor: 2.371

2.  Novel proteases from the genome of the carnivorous plant Drosera capensis: Structural prediction and comparative analysis.

Authors:  Carter T Butts; Jan C Bierma; Rachel W Martin
Journal:  Proteins       Date:  2016-07-13

Review 3.  Cysteine cathepsins: their role in tumor progression and recent trends in the development of imaging probes.

Authors:  Reik Löser; Jens Pietzsch
Journal:  Front Chem       Date:  2015-06-23       Impact factor: 5.221

4.  Modeling of the bacterial luciferase-flavin mononucleotide complex combining flexible docking with structure-activity data.

Authors:  L Y Lin; T Sulea; R Szittner; V Vassilyev; E O Purisima; E A Meighen
Journal:  Protein Sci       Date:  2001-08       Impact factor: 6.725

5.  Cysteine proteases bleomycin hydrolase and cathepsin Z mediate N-terminal proteolysis and toxicity of mutant huntingtin.

Authors:  Tamara Ratovitski; Ekaterine Chighladze; Elaine Waldron; Ricky R Hirschhorn; Christopher A Ross
Journal:  J Biol Chem       Date:  2011-02-10       Impact factor: 5.157

6.  'Patchiness' and basic cancer research: unravelling the proteases.

Authors:  Surinder M Soond; Maria V Kozhevnikova; Andrey A Zamyatnin
Journal:  Cell Cycle       Date:  2019-06-24       Impact factor: 4.534

7.  Synergistic antitumor effects of combined cathepsin B and cathepsin Z deficiencies on breast cancer progression and metastasis in mice.

Authors:  Lisa Sevenich; Uta Schurigt; Kathrin Sachse; Mieczyslaw Gajda; Fee Werner; Sebastian Müller; Olga Vasiljeva; Anne Schwinde; Nicole Klemm; Jan Deussing; Christoph Peters; Thomas Reinheckel
Journal:  Proc Natl Acad Sci U S A       Date:  2010-01-21       Impact factor: 11.205

Review 8.  Cysteine cathepsin proteases: regulators of cancer progression and therapeutic response.

Authors:  Oakley C Olson; Johanna A Joyce
Journal:  Nat Rev Cancer       Date:  2015-12       Impact factor: 60.716

Review 9.  The role of cathepsin X in cell signaling.

Authors:  Janko Kos; Zala Jevnikar; Natasa Obermajer
Journal:  Cell Adh Migr       Date:  2009-04-13       Impact factor: 3.405

10.  Cathepsin X is secreted by human osteoblasts, digests CXCL-12 and impairs adhesion of hematopoietic stem and progenitor cells to osteoblasts.

Authors:  Nicole D Staudt; Wilhelm K Aicher; Hubert Kalbacher; Stefan Stevanovic; Adriana K Carmona; Matthew Bogyo; Gerd Klein
Journal:  Haematologica       Date:  2010-05-21       Impact factor: 9.941

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.